NR5A2 as a potential target for exercise to improve metabolic syndrome

被引:0
|
作者
Meng, Lingxiu [1 ]
Dong, Fusheng [2 ]
Deng, Junguo [1 ]
机构
[1] Qinhuangdao Second Hosp, Dept Cardiol, Qinhuangdao 066600, Hebei, Peoples R China
[2] Qinhuangdao Second Hosp, Dept Anesthesiol, Qinhuangdao 066600, Hebei, Peoples R China
来源
AGING-US | 2023年 / 15卷 / 07期
关键词
LIVER RECEPTOR HOMOLOG-1; DIFFERENTIATION;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background: Metabolic syndrome is a syndrome of a variety of metabolic disorders. Exercise is beneficial to the human body. However, the association of NR5A2 and exercise with metabolic syndrome remains unclear. Methods: Download the GSE10540 and GSE12385 from GEO database. Bioinformatics analysis was used to screen the hub molecular of the metabolic syndrome. Forty 3-week-old C57BL/6J male mice were used in this study. The mean body weight was (17.5 +/- 2.1) g. After 10 days of adaptive feeding, they were randomly divided into 4 groups according to the random number table method: Model + Exercise (n = 10), Model (n = 10), Model/NR5A2-OE (n = 10), Model/NR5A2-KO (n = 10). Western Blotting was performed to detect the expression of hub genes and signaling pathway. Results: There were 349 DEGs in GSE10540 and 49 DEGs in GSE12385. 10 core genes were obtained. GO showed that differentially expressed genes were mainly enriched in vascular morphogenesis, contractile fiber fraction, chemotaxis, and MAPK cascade regulation. KEGG showed that MAPK signaling pathway was a significant section in the metabolic syndrome. PIK3R2, STRA8, FLT1, DMRT1, FGF22, NR5A2, and FLT were up-regulated and PRDM14, POU5F1, and KDR were down-regulated in metabolic syndrome after exercise. Conclusion: The expression of NR5A2 is down-regulated in metabolic syndrome, and exercise can increase the expression level of NR5A2. NR5A2 might be used as a potential target for exercise to improve metabolic syndrome.
引用
收藏
页码:2485 / 2502
页数:18
相关论文
共 50 条
  • [41] Epithelial Nr5a2 heterozygosity cooperates with mutant Kras in the development of pancreatic cystic lesions
    Cobo, Isidoro
    Iglesias, Mar
    Flandez, Marta
    Verbeke, Caroline
    del Pozo, Natalia
    Llorente, Miriam
    Lawlor, Rita
    Luchini, Claudio
    Rusev, Borislav
    Scarpa, Aldo
    Real, Francisco X.
    JOURNAL OF PATHOLOGY, 2021, 253 (02): : 174 - 185
  • [42] Targeting LRH-1/NR5A2 to treat type 1 diabetes mellitus
    Cobo-Vuilleumier, Nadia
    Lorenzo, Petra, I
    Gauthier, Benoit R.
    CELL STRESS, 2018, 2 (06) : 141 - 143
  • [43] The Major Prognostic Features of Nuclear Receptor NR5A2 in Infiltrating Ductal Breast Carcinomas
    Chang, Li-Yun
    Liu, Li-Yu D.
    Roth, Don A.
    Kuo, Wen-Hung
    Hwa, Hsiao-Lin
    Chang, King-Jen
    Hsieh, Fon-Jou
    INTERNATIONAL JOURNAL OF GENOMICS, 2015, 2015
  • [44] Nuclear receptor NR5A2 is involved in the calreticulin gene regulation during renal fibrosis
    Arvaniti, Eleni
    Vakrakou, Athina
    Kaltezioti, Valeria
    Stergiopoulos, Athanasios
    Prakoura, Niki
    Politis, Panagiotis K.
    Charonis, Aristidis
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2016, 1862 (09): : 1774 - 1785
  • [45] LRH-1/NR5A2 interacts with the glucocorticoid receptor to regulate glucocorticoid resistance
    Michalek, Svenja
    Goj, Thomas
    Plazzo, Anna Pia
    Marovca, Blerim
    Bornhauser, Beat
    Brunner, Thomas
    EMBO REPORTS, 2022, 23 (09)
  • [46] Nuclear receptor NR5A2 and bone: gene expression and association with bone mineral density
    Riancho, Jose A.
    Liu, Yongjun
    Sainz, Jesus
    Garcia-Perez, Miguel A.
    Olmos, Jose M.
    Bolado-Carrancio, Alfonso
    Valero, Carmen
    Perez-Lopez, Javier
    Cano, Antonio
    Yang, Tielin
    Sanudo, Carolina
    Deng, Hong-Wen
    Rodriguez-Rey, Jose C.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2012, 166 (01) : 69 - 75
  • [47] NUCLEAR RECEPTOR NR5A2 IS INVOLVED CALRETICULIN GENE REGULATION DURING RENAL FIBROSIS
    Arvaniti, Eleni
    Vakrakou, Athina
    Kaltezioti, Valeria
    Prakoura, Niki
    Politis, Panagiotis
    Charonis, Aristidis
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 366 - 366
  • [48] TARGETING NUCLEAR RECEPTOR NR5A2 IMPROVES EXOCRINE, ENDOCRINE ARCHITECTURE AND FUNCTIONS IN CHRONIC PANCREATITIS
    Galande, Sheethal
    Kuruva, Murali M.
    Ranjeet, K. T.
    Krishna, V. V.
    Sasikala, Mitnala
    Duvvur, Nageshwar R.
    GASTROENTEROLOGY, 2020, 158 (06) : S871 - S871
  • [49] Overexpression of NR5A2/LRH1 in pancreatic cancer and possible association with clinical outcome
    Dong, Xiaoqun
    Li, Yanan
    Fisher, William E.
    Chang, Ping
    Abbruzzese, James L.
    Li, Donghui
    CANCER RESEARCH, 2011, 71
  • [50] MicroRNA-433-3p enhances chemosensitivity of glioma to cisplatin by downregulating NR5A2
    Li, Jun
    Gu, Jingshun
    Wang, Juntong
    You, Aiwu
    Zhang, Yuyan
    Rao, Guomin
    Li, Shuang
    Ge, Xuehua
    Zhang, Kun
    Wang, Dongchun
    BRAIN AND BEHAVIOR, 2022, 12 (12):